Collectively, these findings indicate that osteoblastic cells produce factors that are able to modify the migration capability of prostate cancer cells and our data suggest that Cx43 may be an important element of the metastatic risk by modulating sensitivity to these bone factors. Here, GJA1 is linked to prostate cancer.